EGFR and neoplasm: Moreover, FeDC-E NPs inhibited phosphorylation of the EGFR as well as the EGFR–ERK–NF-κB signaling pathways of the EGFR overexpressing cells along with the expression of the downstream tumor promoting proteins MMP-9 and XIAP.